← Leaderboards
Dong Chang
University Of Washington
$691,393
Attributed
$691,393
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $632.5K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$691,393 · 2
By mechanism
R01$632,507 · 1
F32$58,886 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Catherine Lee Hough$13,618,900
- Kate E. Macduffie$4,374,692
- Claire Johanna Creutzfeldt$3,722,990
- John Chris Feudtner$9,337,484
- Gustavo Matute-Bello$3,581,832
Others in their field
Top investigators on “Critical Illness”
- Jonathan Michael Dean · University Of Utah$52,116,961
- Robert H Tukey · University Of California San Diego$50,968,168
- Mark R Farfel · Hugo W. Moser Res Inst Kennedy Krieger$37,361,278
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$35,137,697
- Steven M Greenberg · Massachusetts General Hospital$31,323,044
- Natalia S Rost · Massachusetts General Hospital$31,323,044
Research focus
Critical IllnessDesignResearch PersonnelAffectComplexBaseAreaAgreementCapillary, UnspecifiedCaliforniaCareerCare PreferenceCaringCell TypeApoptosisClinical TrialsClinical SciencesBronchoalveolar Lavage FluidCommunicationClinical AssessmentsConsensusConsolidated Framework For Implementation ResearchContextual FactorsCharacteristics
Grant awards (2)
A Type 2 Hybrid Effectiveness-Implementation Study of Time Limited Trials to Reduce Potentially Non-Beneficial Treatments for Critically Ill Patients with Advanced Medical Illnesses$632,507
R01 · FY2025 · AG · contact PI
A proteomics approach to study the mechanisms of Fas-induced lung fibrosis$58,886
F32 · FY2007 · HL · contact PI